Integrated Oncology Learning - Details
|
|
A Focus on Chronic Lymphocytic Leukemia A Three-Part Integrated Program
This integrated curriculum consists of 3 modules addressing the pathobiology of chronic lymphocytic leukemia (CLL) and the treatment of and supportive care for patients with CLL. Chaired by: William Wierda, MD, PhD; Anders Österborg, MD, PhD |
Approved for [ Log in to see a status bar view of your new, in progress, and completed activities ]
Management of Your Patients With CLL in the Relapsed/Refractory Disease Setting
Activities beginning now through April 2009
Module Description & Instructions
Module Description & Instructions| Date Available | Title of Activity |
|
FEB
2009
|
E-LERT: Recent Advances in Chronic Lymphocytic Leukemia From the 2008 American Society of Hematology Meeting
Expert review highlighting key abstracts from ASH 2008 available for you to view online or download as a podcast
Activity Release Date: February 27, 2009
|
|
MAR
2009
|
Cancer Summaries & Commentaries Vol. 2, No. 2: Defining New Therapeutic Options for Chronic Lymphocytic Leukemia
Online publication and audio interview reviewing the most clinically relevant 2008 American Society of Hematology Annual Meeting abstracts
Activity Release Date: March 10, 2009
|
|
MAR
2009
|
OncoLogue™: Treatment Advances in Chronic Lymphocytic Leukemia
Online Oncology Dialogue regarding issues that you face in managing patients with relapsed/refractory CLL
Activity Release Date: March 18, 2009
|
|
MAR
2009
|
Interactive Online Case Study: Treatment of a Patient With Chronic Lymphocytic Leukemia Refractory to Fludarabine-Based Therapy
Clinical case scenario emphasizing current standards of care and practical aspects of treatments
Activity Release Date: March 31, 2009
|
|
APR
2009
|
Lecture: Current Trends in Leukemia, Lymphoma, and MyelomaLive meeting and on-demand Webcasts reviewing study design and results from 2008 American Society of Hematology Annual Meeting abstracts
Activity Release Date: April 15, 2009
|
IOL Overview & Purpose
The understanding of the pathobiology of and treatment options for CLL is rapidly evolving, with new treatments and improvements on existing therapies continuously emerging. However, a critical need to improve survival in CLL still remains because transplantation is the only potential for cure, and most treatment guidelines are based on level 2 data. This sets the stage for Integrated Oncology Learning: A Focus on Chronic Lymphocytic Leukemia to apprise clinicians of advances in diagnostic and prognostic tools and potential applications for new treatments. Moreover, the complexity of data and rapid generation of information dictate a need for continual learning with varied formats and the opportunity for interaction.
What is Integrated Oncology Learning?
A curriculum-based educational program for oncologists and hematologists from PER that is:
•Comprehensive: complete learning opportunities from a diverse team of experts
•Personalized: distinct activities in a variety of formats you can complete in any sequence
•Synergistic: modular programs consisting of related activities
•Certified: allows you to earn valuable CME credit
New to PER?
Register now for free access to Integrated Oncology Learning and other online CME activities, Email Updates, and personalized CME management!
Educational Grants
An educational grant for this Integrated Oncology Learning was provided by:
- GlaxoSmithKline
Continuing Education Information
Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Selected activities approved for AMA PRA Category 1 Credit™
Certificates will be provided after the successful completion of each certified activity.